Category listing: » All » Frozen Pages » 2023
See the hierarchical view of this category.
Sub-categories
- February 2023 ( » All » Frozen Pages » 2023 » February 2023)
- May 2023 ( » All » Frozen Pages » 2023 » May 2023)
- July 2023 ( » All » Frozen Pages » 2023 » July 2023)
- August 2023 ( » All » Frozen Pages » 2023 » August 2023)
- September 2023 ( » All » Frozen Pages » 2023 » September 2023)
- October 2023 ( » All » Frozen Pages » 2023 » October 2023)
- November 2023 ( » All » Frozen Pages » 2023 » November 2023)
- December 2023 ( » All » Frozen Pages » 2023 » December 2023)
Pages
- Beyond target chemicals: Updating the NORMAN Prioritization Scheme to Support the EU Chemical Strategy with Semi-quantitative Suspect/Non-target screening data
- Biflavonoid methylchamaejasmin and Khaya grandifoliola extract inhibit inflammasome in THP-1 cells model of neuroinflammation
- Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer’s Disease Patients?
- Converging Peripheral Blood MicroRNA Profiles in Idiopathic Parkinson’s Disease and Progressive Supranuclear Palsy
- DS-PACK: Tool assembly for the end-to-end support of controlled access human data sharing
- Dopamine-iron homeostasis interaction rescues mitochondrial fitness in Parkinson’s disease
- Education as risk factor of mild cognitive impairment: the link to the gut microbiome
- Failure to repair damaged NAD(P)H blocks de novo serine synthesis in human cells
- Federated Electronic Health Records for the European Health Data Space: An architecture proposal to break the privacy-exploitation barrier
- Gene regulatory network inference from single-cell data using optimal transport
- Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.1290A>G (p.T351A) or c.2067A>G (p.T610A) in the RHOT1 gene encoding Miro1
- Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.815G>A (p.R272Q) or c.1348C>T (p.R450C) in the RHOT1 gene encoding Miro1
- Genetic landscape of Parkinson’s disease in Luxembourg
- Harmonized quality assurance/quality control provisions to assess completeness and robustness of MS1 data preprocessing for LC-HRMS-based suspect screening and non-targeted analysis
- Identifiability of Differential-Algebraic Systems
- Impaired dopaminergic neuronal differentiation in GBA associated Parkinson’s disease midbrain organoids is accompanied by an increased progenitor pool in cell cycle arrest
- InChI Isotopologue and Isotopomer Specifications
- Levodopa-induced Dyskinesia in Parkinson's Disease: Insights from cross-cohort prognostic analysis using machine learning
- Luxembourg Parkinson's study - comprehensive baseline analysis of Parkinson's disease and atypical parkinsonism
- Metabolite identification in metabolic phenotyping
- Mild cognitive impairment in Parkinson’s disease is not associated with specific microbial community changes
- Modeling early phenotypes of Parkinson’s disease by age-induced midbrain-striatum assembloids
- NORMAN Guidance on Suspect and Non-Target Screening in Environmental Monitoring
- Non-Target Screening of Surface Water Samples to Identify Exposome-Related Pollutants: A Case Study from Luxembourg
- Omics data integration suggests a potential idiopathic Parkinson’s disease signature
- Parkinson's disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss
- Per- and polyfluoroalkyl substances (PFAS) in PubChem: 7 million and growing
- Polarization of multi-agent gradient flows over manifolds with application to opinion dynamics
- Predictive Models for Health Deterioration: Understanding Disease Pathways for Personalized Medicine
- Programme Dementia Prevention (pdp): A Nationwide Program for Personalized Prevention in Luxembourg
- Progression Subtypes in Parkinson's Disease: An In- depth Analysis Based on Longitudinal Cohorts and Its Impact on Clinical Trial Design
- Seizure-induced increase in microglial cell population in the developing zebrafish brain
- Should transformation products change the way we manage chemicals?
- SinCMat : A single-cell based method for predicting maturation transcription factors
- Single cell transcriptome analysis of the THY-Tau22 mouse model of Alzheimer's disease reveals sex-dependent dysregulations
- Single-Cell Cortical Transcriptomics Reveals Common and Distinct Pathway Activity Signatures in Alzheimer’s and Parkinson’s Disease
- Socio-ethical challenges and opportunities to advance diversity, equity, and inclusion in digital medicine: Narrative Review
- Ten Simple Rules For Successful Development And Implementation Of Digital Health Solutions
- The SYSCID map: a graphical and computational resource of molecular mechanisms across rheumatoid arthritis, systemic lupus erythematosus and inflammatory bowel disease
- Trans-ancestry polygenic models for the prediction of LDL blood levels: an analysis in UK Biobank and Taiwan Biobank
- Visualization of automatically combined disease maps and pathway diagrams for rare diseases
